Moleculin Biotech, Inc.MBRXEarnings & Financial Report
Nasdaq
NextApr 30, 2026
MBRX Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-5.9M
Net Profit
$-25.4M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.68
Moleculin Biotech, Inc. Q3 2025 Financial Summary
Moleculin Biotech, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-25.4M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-25.4M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Moleculin Biotech, Inc. Annual Revenue by Year
Moleculin Biotech, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $38.2M | $30.8M | $25.6M | $23.4M | $16.9M | $21.0M | $21.6M | $20.4M |
| Liabilities | $12.1M | $9.3M | $7.9M | $15.9M | $10.9M | $21.0M | $28.8M | $47.3M |
| Equity | $26.1M | $21.6M | $17.7M | $7.5M | $6.0M | $42000 | $-7.2M | $-26.9M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-5.4M | $-6.7M | $-5.9M | $-6.1M | $-5.1M | $-4.6M | $-5.6M | $-7.2M |